SS

Shalin Shah

Chief Executive Officer

Marius Pharmaceuticals

Marius Pharmaceuticals Pipeline

DrugIndicationPhase
KYZATREXTestosterone replacement therapy (TRT) in adult men with low/no testosterone due to certain medical conditionsApproved
KYZATREX (Investigation)TRT in men with obesity and testosterone deficiencyResearch